Emma Bjorgum is the Vice President, Client Services, DNA in the Nucleic Acid Business Unit for Aldevron.
Emma has been working in the cell and gene therapy industry for over 10 years. Prior to her current position, Emma served as Director of Client Development at Aldevron. Her prior experience was at Millipore Sigma within the Viral and Gene Therapy Manufacturing business unit as a Business Development Manager. She also worked for Be The BioTherapies as a Business and Market Analyst, and started her career at Aldevron in Client Relations.
Emma holds a degree in Biology from Concordia College in Moorhead, MN
Also Speaking
Ramona Repaczki-Jones
Executive Director, Commercial Treatment Center Operations, Cell Therapy • Iovance Biotherapeutics Inc
2 December 2022
John Balchunas
Workforce Director • The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
31 October 2022
Event Info
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023